Recombinant 30S ribosomal protein S19 (rpsS)

Shipped with Ice Packs
In Stock

Description

Ribosome Assembly

  • Binds 16S rRNA and interacts with ribosomal protein S13 to stabilize the head domain of the 30S subunit .

  • Facilitates maturation of rRNA helices 31 and 33b, critical for translation fidelity .

  • Requires assembly chaperones like RimM for proper integration into the 30S subunit .

Disease Associations

  • Mutations in RPS19 cause Diamond-Blackfan anemia (DBA), a congenital erythroid progenitor maturation disorder .

  • Dysregulation disrupts ribosome biogenesis, leading to nucleolar stress and apoptosis in erythroid cells .

With RimM Protein

  • RimM binds RPS19 via its N-terminal β-barrel domain, facilitating 30S subunit maturation .

  • Mutations in RimM (e.g., YY→AA) reduce RPS19 binding efficiency, impairing 16S rRNA processing .

  • Genetic suppressors in rpsS (S19) or rpsM (S13) restore ribosome function in RimM-deficient strains .

RNA-Protein Interactions

  • Directly contacts helix 33b of 16S rRNA, inducing conformational changes critical for subunit assembly .

  • Forms a dynamic bridge (B1a/B1b) with 23S rRNA in the 70S ribosome, influencing translational accuracy .

Experimental Use Cases

  • Pull-down assays: GST-tagged RPS19 identifies interactors like PIM1 kinase and spliceosome components .

  • NMR spectroscopy: Used to resolve RimM-RPS19 binding dynamics in Thermus thermophilus .

  • Drug target studies: Binds tetracycline-family antibiotics (e.g., tigecycline) in bacterial ribosomes .

Sequence and Domain Analysis

  • Conserved domains: Ribosomal_S19 (PF00203) in bacteria/eukaryotes .

  • Post-translational modifications: None reported; N-terminal His-tags commonly added for purification .

Key Research Findings

  1. Proteomics screens identified 159 RPS19 interactors, including helicases, splicing factors, and kinases .

  2. RimM-RPS19 binding stabilizes late-stage 30S assembly intermediates, preventing rRNA misfolding .

  3. Human recombinant RPS19 restores erythroid differentiation in DBA patient-derived cell models .

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary depending on the purchasing method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional charges will apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect the contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receiving. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag type, please inform us, and we will prioritize developing it.
Synonyms
rpsS; rps19; 30S ribosomal protein S19
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
2-93
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Thermus thermophilus
Target Names
rpsS
Target Protein Sequence
PRSLKKGVF VDDHLLEKVL ELNAKGEKRL IKTWSRRSTI VPEMVGHTIA VYNGKQHVPV YITENMVGHK LGEFAPTRTY RGHGKEAKAT KKK
Uniprot No.

Target Background

Function
Protein S19 complexes with S13 and binds strongly to the 16S ribosomal RNA.
Protein Families
Universal ribosomal protein uS19 family

Q&A

What is the primary role of 30S ribosomal protein S19 in prokaryotic and eukaryotic systems?

The 30S ribosomal protein S19 (rpsS) in prokaryotes is primarily a component of the small ribosomal subunit, contributing to ribosome assembly, stability, and function during protein synthesis. In eukaryotes, the orthologous RPS19 is part of the 40S subunit. Beyond its structural role, RPS19 participates in rRNA processing pathways, particularly in yeast models. The protein exhibits remarkable conservation across species, indicating its fundamental importance in translation.

In prokaryotic systems like E. coli, rpsS is essential for the proper folding of 16S rRNA and affects the binding of initiation factors. The protein contains specific binding domains that facilitate interactions with both rRNA and other ribosomal proteins. For eukaryotic RPS19, mutations have been linked to Diamond Blackfan anemia, suggesting its critical role in erythropoiesis .

How does the amino acid sequence of rpsS contribute to its functionality?

The E. coli 30S ribosomal protein S19 consists of 91 amino acids with the sequence: "PRSLKKGPFI DLHLLKKVEK AVESGDKKPL RTWSRRSTIF PNMIGLTIAV HNGRQHVPVF VTDEMVGHKL GEFAPTRTYR GHAADKKAKK K" . This sequence contains several key features:

RegionAmino Acid PositionFunction
N-terminal region1-20Contains basic residues important for rRNA binding
Central domain21-60Involved in protein-protein interactions within the ribosome
C-terminal region61-91Contains residues crucial for proper ribosomal assembly
Lysine-rich segmentsThroughout sequenceFacilitate electrostatic interactions with negatively charged rRNA

The high proportion of basic amino acids (lysine, arginine) enables strong interactions with the negatively charged phosphate backbone of rRNA. The secondary structure typically includes alpha helices and beta sheets that form a compact, globular domain with surface-exposed regions that participate in multiple molecular interactions.

What methodologies should researchers employ to verify the functional integrity of recombinant rpsS?

Verifying functional integrity of recombinant rpsS requires multiple approaches:

  • Structural verification: Circular dichroism spectroscopy to confirm proper folding compared to native protein.

  • RNA binding assay: Electrophoretic mobility shift assays (EMSA) to assess binding to 16S rRNA fragments.

  • Ribosome incorporation test: In vitro reconstitution studies where recombinant rpsS is added to rpsS-depleted ribosomes to restore translation activity.

  • Translation efficiency assessment: Polysome profiling and in vitro translation systems to measure functional activity.

  • Interaction validation: Pull-down assays to confirm interaction with known binding partners such as other ribosomal proteins and processing factors .

For optimal results, researchers should compare activity metrics between recombinant and native forms, using concentration gradients to establish dose-response relationships.

How can response surface methodology (RSM) be applied to optimize expression and purification of recombinant rpsS?

Response Surface Methodology (RSM) offers a sophisticated approach to optimize recombinant rpsS expression and purification by systematically evaluating multiple variables simultaneously. Implementation involves:

  • Variable selection: Key parameters typically include induction temperature (18-37°C), IPTG concentration (0.1-1.0 mM), induction time (2-24 hours), and media composition.

  • Experimental design selection: Central composite design (CCD) or Box-Behnken design is recommended, with CCD providing more comprehensive coverage of experimental space.

  • Model development: Following data collection, develop a second-order polynomial model to relate expression yield/purity to experimental variables .

Design TypeNumber of FactorsNumber of RunsAdvantages
Factorial Design2-44-16Simple, identifies main effects
Central Composite2-69-53Provides good prediction, models curvature
Box-Behnken3-513-41Efficient, no extreme conditions

The analysis should yield an optimized set of conditions that maximize both yield and purity. Validation experiments should confirm model predictions, with adjustments made as necessary for scale-up procedures.

What strategies should be employed to address data contradictions when analyzing rpsS interactome studies?

When analyzing contradictions in rpsS interactome data, researchers should apply structured evaluation methodologies such as the (α, β, θ) notation system, where:

  • α represents the number of interdependent items in the dataset

  • β represents the number of contradictory dependencies identified

  • θ represents the minimal number of required Boolean rules to assess these contradictions

For example, in a study identifying 159 proteins interacting with RPS19, contradictions may emerge between different experimental methods (e.g., yeast two-hybrid versus co-immunoprecipitation) . These contradictions should be systematically categorized and addressed using the following protocol:

  • Contradiction mapping: Create a comprehensive table of all protein interactions detected, noting which experimental method produced each result.

  • Boolean rule formulation: Develop logical rules to evaluate contradictory findings (e.g., IF method A shows interaction AND method B shows no interaction, THEN additional validation required).

  • Reconciliation analysis: Apply techniques such as network analysis and hierarchical clustering to identify patterns in contradictory data.

  • Validation framework: Design targeted experiments to specifically address contradictions, prioritizing those with highest biological significance.

This systematic approach provides a framework that helps maintain data integrity while extracting maximum value from complex interaction datasets.

How does the rpsS interactome extend our understanding of its non-canonical functions?

Proteomics studies have revealed that rpsS/RPS19 interacts with 159 proteins beyond its ribosomal context, suggesting extensive non-canonical functions. These interactions span multiple cellular compartments and biological processes :

Functional CategoryNumber of InteractorsRepresentative ExamplesPotential Non-canonical Functions
NTPases (ATPases and GTPases)5-Energy-dependent regulatory processes
Hydrolases/Helicases19-RNA metabolism and processing
Splicing Factors5-mRNA processing regulation
Transcription Factors11-Gene expression regulation
DNA/RNA-binding proteins53-Nucleic acid metabolism
Kinases3PIM1Signal transduction pathways

These interactions suggest rpsS functions in:

  • Transcriptional regulation: Direct interaction with transcription factors indicates potential roles in gene expression control beyond translation.

  • RNA processing: Associations with helicases and splicing factors suggest involvement in RNA maturation pathways.

  • Signal transduction: Interaction with kinases like PIM1 points to roles in cellular signaling cascades .

  • Extracellular functions: The RPS19 dimer exhibits monocyte chemotactic activity, suggesting immunomodulatory roles outside the cell .

To investigate these functions, researchers should employ techniques including proximity-dependent biotin identification (BioID), CRISPR-based genetic screens, and quantitative interaction proteomics under various cellular conditions.

What are the methodological challenges in studying rpsS mutations and their impact on ribosome biogenesis?

Studying rpsS mutations presents several methodological challenges that require specific experimental approaches:

The most effective experimental design employs a combination of in vitro biochemical assays, in vivo functional studies, and computational modeling to comprehensively characterize mutation effects.

How do mutations in RPS19 contribute to Diamond-Blackfan anemia pathogenesis, and what experimental models best study this relationship?

Mutations in RPS19 account for approximately 25% of Diamond-Blackfan anemia (DBA) cases, making it the most commonly mutated gene in this rare congenital erythroid hypoplasia. The pathogenesis involves:

  • Defective ribosome biogenesis: RPS19 mutations impair 40S ribosomal subunit assembly, leading to nucleolar stress and activation of p53-dependent pathways.

  • Selective erythroid defect: Despite RPS19 being ubiquitously expressed, erythroid progenitors show particular sensitivity to its dysfunction .

  • Translational deficiency: Specific mRNAs critical for erythropoiesis may be differentially affected by altered ribosome composition.

  • Extra-ribosomal function disruption: Loss of RPS19 interactions with proteins such as FGF2 may contribute to the erythroid-specific phenotype .

Optimal experimental models include:

Model SystemAdvantagesLimitationsKey Applications
Patient-derived iPSCsAuthentic human genetic backgroundGenetic variability between patientsDisease modeling, drug screening
CRISPR-edited cell linesPrecise genetic controlLimited to in vitro systemsMechanism studies, interactome analysis
Zebrafish modelsRapid development, visualizable erythropoiesisEvolutionary distance from humansIn vivo phenotyping, drug screening
Mouse modelsMammalian physiologyDifferences in erythropoiesis regulationLong-term studies, tissue interactions

Researchers should prioritize models that allow dynamic assessment of both ribosome biogenesis and erythroid differentiation processes simultaneously.

What emerging therapeutic strategies target rpsS/RPS19 for disease intervention?

Emerging therapeutic strategies targeting rpsS/RPS19 are being developed for conditions like Diamond-Blackfan anemia, with several innovative approaches:

  • Gene therapy approaches: Lentiviral vectors expressing wild-type RPS19 have shown promise in restoring erythropoiesis in patient-derived cells. Current research focuses on optimizing delivery systems and expression regulation.

  • Chemical chaperones: Small molecules that stabilize mutant RPS19 protein folding are being screened. Compounds such as specific leucine derivatives have shown preliminary efficacy in rescuing ribosome assembly.

  • p53 pathway modulators: Since RPS19 deficiency activates p53-mediated apoptosis, compounds like pifithrin-α that temporarily inhibit p53 are being tested as potential therapeutic agents.

  • Translation-enhancing compounds: Molecules that promote read-through of premature termination codons in nonsense RPS19 mutations show promise in preliminary studies.

  • Targeted proteostasis modulation: Approaches that selectively inhibit protein degradation pathways have demonstrated efficacy in stabilizing certain RPS19 mutants.

When designing studies to evaluate these interventions, researchers should implement comprehensive assessment protocols that measure not only direct effects on RPS19 levels but also downstream impacts on ribosome assembly, erythroid differentiation, and global translation.

What are the most promising methodological advances for studying rpsS structure-function relationships?

Recent technological innovations offer unprecedented opportunities for understanding rpsS structure-function relationships:

  • Single-molecule techniques: Advanced methods like single-molecule FRET and optical tweezers now enable real-time visualization of rpsS dynamics during ribosome assembly and function. These approaches reveal transient states previously inaccessible through bulk measurements.

  • Time-resolved cryo-EM: Combining microfluidic mixing devices with rapid freezing allows visualization of conformational changes in rpsS during ribosome assembly at millisecond timescales.

  • Computational advances:

    • AlphaFold2 and RoseTTAFold predictions provide structural insights for regions difficult to resolve experimentally

    • Molecular dynamics simulations at microsecond timescales reveal dynamic interactions within the ribosomal context

  • Chemical biology approaches: Photo-crosslinking amino acids incorporated into rpsS at specific positions enable precise mapping of transient interaction interfaces during ribosomal assembly and function.

  • Native mass spectrometry: This technique allows determination of rpsS binding partners and post-translational modifications in near-native conditions, preserving important weak interactions.

Researchers should consider combining these approaches in integrated workflows to connect structural information with functional outcomes at multiple levels of biological organization.

How can systems biology approaches enhance our understanding of rpsS in cellular regulatory networks?

Systems biology offers powerful frameworks for contextualizing rpsS functions within broader cellular networks:

  • Multi-omics integration: Combining transcriptomics, proteomics, and metabolomics data from cells with perturbed rpsS expression reveals system-wide impacts. This approach has identified unexpected connections between rpsS and cellular stress response pathways .

  • Network modeling approaches:

    • Protein-protein interaction networks: The identification of 159 interacting proteins suggests rpsS functions as a hub connecting translation with other cellular processes

    • Bayesian network analysis: Helps infer causal relationships between rpsS perturbations and downstream effects

    • Flux balance analysis: Models how rpsS alterations affect metabolic pathways

  • Single-cell multi-omics: Reveals cell-to-cell variability in responses to rpsS perturbation, identifying subpopulations with distinct regulatory states.

  • Machine learning applications: Deep learning models trained on multi-omics data can predict cellular responses to novel rpsS mutations or post-translational modifications.

For effective implementation, researchers should:

  • Design experiments with sufficient biological replicates for robust statistical inference

  • Collect time-course data to capture dynamic responses

  • Include appropriate controls for distinguishing specific rpsS effects from general ribosomal stress

  • Employ computational validation through techniques like cross-validation and bootstrapping

How should researchers address contradictory findings in rpsS interaction studies across different experimental platforms?

When confronted with contradictory findings in rpsS interaction studies, researchers should implement a structured contradiction management approach based on the (α, β, θ) framework :

  • Systematic contradiction categorization:

    • Classify contradictions by experimental method (α = 2 for contradictions between two methods)

    • Quantify the number of contradictory dependencies (β)

    • Determine minimal Boolean rules needed to assess these contradictions (θ)

  • Methodological validation hierarchy:

    • Establish a hierarchy of evidence based on method specificity and sensitivity

    • Direct biochemical methods (e.g., pull-downs) typically outweigh library-based methods (e.g., yeast two-hybrid)

    • Confirmations in multiple species increase confidence in conserved interactions

  • Contradiction resolution protocol:

    • For critical interactions, implement orthogonal validation using at least three independent techniques

    • Systematically vary experimental conditions to identify context-dependent interactions

    • Consider stoichiometry and competition effects that may explain apparent contradictions

  • Data integration framework:

    • Apply Bayesian integration methods to assign confidence scores to each interaction

    • Develop consensus interaction maps that incorporate uncertainty metrics

    • Maintain transparency by reporting all contradictory results rather than selecting "representative" data

This systematic approach not only addresses contradictions but converts them into valuable insights about context-dependent interactions and methodological limitations.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.